Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in KaloBios Pharmaceuticals, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit – KBIO

Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news